Biotechnology start-up TC BioPharm (TCB) has been given the go-ahead to create human cell therapy products at its new Scottish lab at Maxim Park in North Lanarkshire.
The multi-million-pound facility includes two independent cleanrooms as well as laboratories and a quality control suit.
TCB’s technology, which uses patients’ own immune cells to target cancer and viral infections, is based on treatments by strategic partner Medinet in Japan. The companies collaborated last year to develop a novel treatment for various different types of cancer.
TCB plans to treat the first cohort of patients this year, working alongside established cancer clinics throughout Scotland. They will treat both cancer patients and individuals with major viral infections, and as well as early-diagnosis HIV patients.
Are you passionate about cancer therapy? Want to work for a small company with global ambitions? TCB is looking for talented people to join their growing team.
Find out about opportunities with TC Biopharm.